Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.

Saved in:
Bibliographic Details
Title: Development of a Diagnostic Autoantibody Assay to a Consensus Motif for the Risk Prediction of Epstein-Barr Virus-Related Multiple Sclerosis.
Authors: McCutcheon KM; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Bodansky A; School of Medicine, Division of Pediatric Critical Care Medicine, University of California San Francisco., Ngo TT; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Caspar C; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Quintana S; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Asaki J; School of Medicine, Division of Pediatric Critical Care Medicine, University of California San Francisco., Zhou J; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Caillier SJ; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Sharathchandra A; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Waldrop G; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Dandekar R; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Zorn K; School of Medicine, Biochemistry and Biophysics, University of California San Francisco., Tubati A; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Gupta S; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Sabatino JJ; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Cuneo R; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Oksenberg J; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Wallin MT; Department of Veterans Affairs, Multiple Sclerosis Center of Excellence, Washington, DC.; University of Maryland School of Medicine, Baltimore; and., Cree BAC; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Hauser SL; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Pleasure S; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco., Derisi J; School of Medicine, Biochemistry and Biophysics, University of California San Francisco.; Chan Zuckerberg Biohub SF, San Francisco, CA., Wilson MR; School of Medicine, Neurology, UCSF Weill Institute for Neurosciences, University of California San Francisco.
Corporate Authors: and the UCSF ORIGINS/EPIC team
Source: Neurology(R) neuroimmunology & neuroinflammation [Neurol Neuroimmunol Neuroinflamm] 2026 May; Vol. 13 (3), pp. e200551. Date of Electronic Publication: 2026 Mar 13.
Publication Type: Journal Article
Journal Info: Publisher: Wolters Kluwer Health/Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 101636388 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2332-7812 (Electronic) Linking ISSN: 23327812 NLM ISO Abbreviation: Neurol Neuroimmunol Neuroinflamm Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2332-7812
DOI:10.1212/NXI.0000000000200551